Status:
COMPLETED
Outcomes of a Novel Magnetically Levitated LVAD: a Multicenter Analysis
Lead Sponsor:
Beijing Anzhen Hospital
Collaborating Sponsors:
Shanghai Chest Hospital
Shanghai Zhongshan Hospital
Conditions:
Heart Failure
Eligibility:
All Genders
Brief Summary
This multicenter, retrospective cohort study evaluates the clinical outcomes associated with a novel fully magnetically levitated left ventricular assist device (LVAD) in patients with advanced heart ...
Detailed Description
Introduction Heart failure (HF) is a progressive condition that represents the final stage of various cardiovascular diseases, where the heart can no longer maintain adequate circulation. End-stage he...
Eligibility Criteria
Inclusion
- All patients implanted with the CH-VAD as the primary device in a post-market approval setting were included.
Exclusion
- \-
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06596499
Start Date
June 1 2022
End Date
August 1 2024
Last Update
September 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100029